Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Histone demethylase KDM2B regulates lineage commitment in normal and malignant hematopoiesis
Jaclyn Andricovich, … , Adlen Foudi, Alexandros Tzatsos
Jaclyn Andricovich, … , Adlen Foudi, Alexandros Tzatsos
Published January 25, 2016
Citation Information: J Clin Invest. 2016;126(3):905-920. https://doi.org/10.1172/JCI84014.
View: Text | PDF
Research Article Hematology

Histone demethylase KDM2B regulates lineage commitment in normal and malignant hematopoiesis

  • Text
  • PDF
Abstract

The development of the hematopoietic system is a dynamic process that is controlled by the interplay between transcriptional and epigenetic networks to determine cellular identity. These networks are critical for lineage specification and are frequently dysregulated in leukemias. Here, we identified histone demethylase KDM2B as a critical regulator of definitive hematopoiesis and lineage commitment of murine hematopoietic stem and progenitor cells (HSPCs). RNA sequencing of Kdm2b-null HSPCs and genome-wide ChIP studies in human leukemias revealed that KDM2B cooperates with polycomb and trithorax complexes to regulate differentiation, lineage choice, cytokine signaling, and cell cycle. Furthermore, we demonstrated that KDM2B exhibits a dichotomous role in hematopoietic malignancies. Specifically, we determined that KDM2B maintains lymphoid leukemias, but restrains RAS-driven myeloid transformation. Our study reveals that KDM2B is an important mediator of hematopoietic cell development and has opposing roles in tumor progression that are dependent on cellular context.

Authors

Jaclyn Andricovich, Yan Kai, Weiqun Peng, Adlen Foudi, Alexandros Tzatsos

×

Figure 1

KDM2B is essential for embryonic development.

Options: View larger image (or click on image) Download as PowerPoint
KDM2B is essential for embryonic development.
(A) Targeting strategy to ...
(A) Targeting strategy to generate the Kdm2b conditional allele. Exons 16–19 were targeted with loxp sites and a neomycin (Neo) cassette flanked by Frt sites. To remove the Neo cassette and generate the Kdm2blox allele, mice were crossed with the actin-Flpe strain. Tissue-specific deletion was achieved by crossing with appropriate Cre strains. Red arrows depict the position of PCR primers for the detection of Kdm2blox (P1:P2) and the recombined allele Kdm2bΔ (P3:P4). (B) Upper left: representative PCR to detect the Kdm2blox allele in tail-tip DNA samples from WT, heterozygous, and homozygous mice. Bottom left: Kdm2bfl/fl MEFs infected with adenoviruses that express GFP or Cre recombinase. PCR of genomic DNA shows excision of the floxed allele upon Cre expression. Asterisk indicates internal PCR control. Right: Western blot showing downregulation of long and short isoforms (arrowheads) of KDM2B from MEF whole-cell lysates. NS, nonspecific. (C and D) Gross images of WT and Kdm2b-null embryos at (C) E9.5 and (D) E10.5. Neural tube defects and excencephaly (white arrows), craniofacial defects (red arrow), and lack of yolk sac vasculature were observed in KO embryos. The red dotted line traces the aorta/AGM. Scale bars: 0.5 mm (C); 1 mm (D). (E) Gross images of E11.5 WT and Tie2-Cre Kdm2bfl/fl embryos. Red dotted line traces the aorta/AGM, and the black arrow points to the heart. Scale bar: 2 mm. (F) Flow cytometric analysis of dissected AGM showing the frequency of double-positive VE-cadherin/CD45 cells. Graph shows the mean ± SEM. n = 3. *P < 0.05. (G) Immunofluorescent staining of aortas from E10.5 embryos for KDM2B (red; nuclear) and c-Kit (green; cell surface). White arrow shows budding hemogenic endothelium and yellow arrow a circulating “stem-like” cell. Nuclei were stained with DAPI (blue). Scale bars: 10 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts